Insiders Ocugen, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 02:17:25 2024-05-17 pm EDT			5-day change	1st Jan Change
1.885 ^USD	-4.80%		+19.81%	+231.30%

May. 15	Ocugen Completes Dosing of Second Group in Stargardt Eye Therapy Safety and Efficacy Study	MT
May. 15	Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST?A Modifier Gene Therapy	CI

Ocugen, Inc. Announces Ramesh Kumar Will Not Stand for Re-Election as Director	Mar. 20	CI
Ocugen, Inc. Appoints Huma Qamar as Chief Medical Officer	Mar. 18	CI
Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board	Jan. 16	CI
Ocugen, Inc. Appoints Connie Collingsworth to the Business Advisory Board	23-09-21	CI
Ocugen, Inc. Announces Executive Changes	23-09-19	CI
Ocugen, Inc. Announces Executive Changes	23-08-15	CI
Ocugen, Inc. Announces Resignation of Quan Vu as Chief Financial Officer	23-08-15	CI
Ocugen, Inc. Announces Business Advisory Board	23-06-05	CI
Ocugen, Inc. Announces Executive Changes	23-03-10	CI
Ocugen, Inc. Appoints Quan A. Vu to Chief Business Officer	23-03-06	CI
Ocugen Appoints Quan Vu as Finance Chief	23-03-06	MT
Ocugen, Inc. Appoints Quan A. Vu as Chief Financial Officer	23-03-06	CI
Insider Sell: Ocugen	23-02-17	MT
Ocugen, Inc. Appoints Quan A. Vu as Chief Business Officer	23-02-01	CI
Insider Sell: Ocugen	23-01-19	MT
Insider Sell: Ocugen	22-12-20	MT
Insider Sell: Ocugen	22-10-14	MT
Ocugen, Inc. Announces Board Changes	22-09-01	CI
Insider Sell: Ocugen	22-07-15	MT
Ocugen Named Among Philadelphia’s ‘2022 Best Places to Work’	22-06-14	AQ

No results for this search